Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.42B | $3.74B | $3.92B | $4.30B | $4.68B | $5.20B | $5.64B | $5.89B |
| Cost of revenue | $2.72B | $3.14B | $3.46B | $4.02B | $4.77B | $5.21B | $1.13B | $5.74B |
| Gross profit | $701.9M | $597.8M | $459.7M | $277.7M | −$91.4M | $655.9M | $4.51B | $4.76B |
| Gross margin | 20.5% | 16.0% | 11.7% | 6.5% | -2.0% | 12.6% | 80.0% | 80.8% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $427.7M | $502.9M | $426.4M | $364.6M | −$664.3M | −$918.7M | −$38.2M | $117.9M |
| EBITDA | $586.3M | $958.7M | $942.1M | $1.04B | −$3.45B | $2.65B | $731.6M | $777.8M |
| Net income | $220.4M | $234.0M | $160.0M | $65.2M | −$4.03B | $1.35B | −$412.1M | −$297.9M |
| Net margin | 6.4% | 6.3% | 4.1% | 1.5% | -86.0% | 26.1% | -7.3% | -5.1% |
| EPS (diluted) | 170.63 | 174.72 | 117.17 | 47.68 | -3116.52 | 652.97 | -2.62 | -1.85 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $5.9B | $-0.77 | $-0.80–$-0.70 | 1 |
| 2027 | $6.1B | $-0.07 | $-0.08–$-0.07 | 1 |
| 2028 | $6.4B | $0.41 | $0.37–$0.42 | 1 |
| 2029 | $6.5B | $1.85 | $1.68–$1.92 | 1 |
Forward consensus · source: Financial Modeling Prep
ORPEA ACT NEW
No one on the platform currently holds ORPEF.
No tracked institution reports a position in ORPEF as of their last filing.
| Execution date | Ratio |
|---|---|
| 2024-03-22 | 1-for-1000reverse |
| 2007-07-31 | 2-for-1 |
No one on the platform has traded ORPEF yet.
| +0.00% |
| $2M |
| — |
| MFCSFMedical Facilities Corporation | $12.76 | +0.47% | $224M | — |
| MKLNFM1 Kliniken AG | $11.73 | +0.00% | $215M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.0× sales vs its 5.5× historical median P/S.
Fair value ≈ $41780 · price $14.22 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.